Infantile haemangioma and β-blockers in otolaryngology
Nicolas Leboulanger(Hôpital Necker-Enfants Malades), Françoise Denoyelle(Hôpital Necker-Enfants Malades), E.N. Garabédian(Sorbonne Université), Amanda Cox(Sorbonne Université)
European Annals of Otorhinolaryngology Head and Neck Diseases
April 19, 2011
Cited by 13
Related Papers
GJB2 Mutations and Degree of Hearing Loss: A Multicenter Study
|The American Journal of Human Genetics|2005|558
IL-21 drives secondary autoimmunity in patients with multiple sclerosis, following therapeutic lymphocyte depletion with alemtuzumab (Campath-1H)
|Journal of Clinical Investigation|2009|299
Role of Propranolol in the therapeutic strategy of infantile laryngotracheal hemangioma
|International Journal of Pediatric Otorhinolaryngology|2009|235
Langerhans cell histiocytosis: therapeutic strategy and outcome in a 30‐year nationwide cohort of 1478 patients under 18 years of age
|British Journal of Haematology|2016|130